Equity Screeners to view more equity screening toolsThe Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also
Bharat Immunologicals Shares Outstanding AnalysisOutstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.
|Bharat Immunologicals||Shares Outstanding||=|
About Shares OutstandingOutstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
|Compare to competition|
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has 43.18M of shares currently outstending. This is 82.67% lower than that of the Healthcare sector, and 84.56% lower than that of Biotechnology industry, The Shares Outstanding for all stocks is 96.97% higher than the company.
Bharat Immunologicals is rated below average in shares outstanding category among related companies.
|Return On Equity||(10.18)%|
|Return On Asset||(9.86)%|
|Price to Earning||262.88X|
|Price to Book||1.12X|
|Price to Sales||1.10X|
|Cash and Equivalents||182.85M|
|Cash per Share||4.25X|
|Debt to Equity||3.80%|
|Book Value Per Share||7.91X|
|Earnings Per Share||(0.99)X|